Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury
Ex vivo lung perfusion (EVLP) has been implemented to increase the number of donor lungs available for transplantation. The use of K(ATP) channel modulators during EVLP experiments may protect against lung ischemia-reperfusion injury and may inhibit the formation of reactive oxygen species. In a rat...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2021-09-01
|
| シリーズ: | Cells |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2073-4409/10/9/2296 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|